journal article
Open Access
Jan 14, 2019
Retinal Deficits Precede Cognitive and Motor Deficits in a Rat Model of Type II Diabetes
Rachael S. Allen
Andrew Feola
Cara T. Motz
Amy L. Ottensmeyer
Kyle C. Chesler
Ryan Dunn
Peter M. Thulé
Machelle T. Pardue
Topics
No keywords indexed for this article. Browse by subject →
References
59
[1]
Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. Available at: https://www.cdc.gov/features/diabetes-statistic-report/index.html.
[2]
King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998; 21: 1414–1431.
10.2337/diacare.21.9.1414
[3]
Klein BE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol. 2007; 14: 179–183.
10.1080/09286580701396720
[4]
Antonetti DA, Barber AJ, Bronson SK, et al. Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes. 2006; 55: 2401–2411.
10.2337/db05-1635
[5]
Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry. 2003; 27: 283–290.
10.1016/s0278-5846(03)00023-x
[6]
Ghirlanda G, Di Leo MA, Caputo S, Cercone S, Greco AV. From functional to microvascular abnormalities in early diabetic retinopathy. Diabetes Metab Rev. 1997; 13: 15–35.
10.1002/(sici)1099-0895(199703)13:1<15::aid-dmr176>3.0.co;2-m
[7]
Aung MH, Kim MK, Olson DE, Thule PM, Pardue MT. Early visual deficits in streptozotocin-induced diabetic Long Evans rats. Invest Ophthalmol Vis Sci. 2013; 54: 1370–1377.
10.1167/iovs.12-10927
[8]
Tyrberg M, Lindblad U, Melander A, Lovestam-Adrian M, Ponjavic V, Andreasson S. Electrophysiological studies in newly onset type 2 diabetes without visible vascular retinopathy. Doc Ophthalmol. 2011; 123: 193–198.
10.1007/s10633-011-9298-6
[9]
Holopigian K, Greenstein VC, Seiple W, Hood DC, Carr RE. Evidence for photoreceptor changes in patients with diabetic retinopathy. Invest Ophthalmol Vis Sci. 1997; 38: 2355–2365.
[10]
Shirao Y, Kawasaki K. Electrical responses from diabetic retina. Prog Retin Eye Res. 1998; 17: 59–76.
10.1016/s1350-9462(97)00005-0
[11]
Holopigian K, Seiple W, Lorenzo M, Carr R. A comparison of photopic and scotopic electroretinographic changes in early diabetic retinopathy. Invest Ophthalmol Vis Sci. 1992; 33: 2773–2780.
[12]
Lecleire-Collet A, Audo I, Aout M, et al. Evaluation of retinal function and flicker light-induced retinal vascular response in normotensive patients with diabetes without retinopathy. Invest Ophthalmol Vis Sci. 2011; 52: 2861–2867.
10.1167/iovs.10-5960
[13]
Kizawa J, Machida S, Kobayashi T, Gotoh Y, Kurosaka D. Changes of oscillatory potentials and photopic negative response in patients with early diabetic retinopathy. Jpn J Ophthalmol. 2006; 50: 367–373.
10.1007/s10384-006-0326-0
[14]
Simonsen SE. The value of the oscillatory potential in selecting juvenile diabetics at risk of developing proliferative retinopathy. Acta Ophthalmol (Copenh). 1980; 58: 865–878.
10.1111/j.1755-3768.1980.tb08312.x
[15]
Severns ML, Johnson MA, Bresnick GH. Methodologic dependence of electroretinogram oscillatory potential amplitudes. Doc Ophthalmol. 1994; 86: 23–31.
10.1007/bf01224625
[16]
Pardue MT, Barnes CS, Kim MK, et al. Rodent hyperglycemia-induced inner retinal deficits are mirrored in human diabetes. Trans Vis Sci Tech. 2014; 3 (3): 6.
10.1167/tvst.3.3.6
[17]
Fletcher EL, Phipps JA, Ward MM, Puthussery T, Wilkinson-Berka JL. Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy. Curr Pharm Des. 2007; 13: 2699–2712.
10.2174/138161207781662920
[18]
Kowluru RA, Chan PS. Oxidative stress and diabetic retinopathy. Exp Diabetes Res. 2007; 2007: 43603.
10.1155/2007/43603
[19]
Raza H, John A, Howarth FC. Increased oxidative stress and mitochondrial dysfunction in zucker diabetic rat liver and brain. Cell Physiol Biochem. 2015; 35: 1241–1251.
10.1159/000373947
[20]
Ly A, Yee P, Vessey KA, Phipps JA, Jobling AI, Fletcher EL. Early inner retinal astrocyte dysfunction during diabetes and development of hypoxia, retinal stress, and neuronal functional loss. Invest Ophthalmol Vis Sci. 2011; 52: 9316–9326.
10.1167/iovs.11-7879
[21]
Fletcher EL, Downie LE, Ly A, et al. A review of the role of glial cells in understanding retinal disease. Clin Exp Optom. 2008; 91: 67–77.
10.1111/j.1444-0938.2007.00204.x
[22]
Muriach M, Flores-Bellver M, Romero FJ, Barcia JM. Diabetes and the brain: oxidative stress, inflammation, and autophagy. Oxid Med Cell Longev. 2014; 2014: 102158.
10.1155/2014/102158
[23]
Lutty GA. Effects of diabetes on the eye. Invest Ophthalmol Vis Sci. 2013; 54: ORSF81–ORSF87.
10.1167/iovs.13-12979
[24]
van Duinkerken E, Klein M, Schoonenboom NS, et al. Functional brain connectivity and neurocognitive functioning in patients with long-standing type 1 diabetes with and without microvascular complications: a magnetoencephalography study. Diabetes. 2009; 58: 2335–2343.
10.2337/db09-0425
[25]
Sherin A, Peeyush KT, Jayanarayanan S, Amee KK, Paulose CS. Decreased cholinergic receptor expression in the striatum: motor function deficit in hypoglycemic and diabetic rats. Cell Mol Neurobiol. 2012; 32: 83–93.
10.1007/s10571-011-9738-6
[26]
Haan M, Espeland MA, Klein BE, et al. Cognitive function and retinal and ischemic brain changes: the Women's Health Initiative. Neurology. 2012; 78: 942–949.
10.1212/wnl.0b013e31824d9655
[27]
Ferguson SC, Blane A, Perros P, et al. Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes. 2003; 52: 149–156.
10.2337/diabetes.52.1.149
[28]
Wessels AM, Rombouts SA, Simsek S, et al. Microvascular disease in type 1 diabetes alters brain activation: a functional magnetic resonance imaging study. Diabetes. 2006; 55: 334–340.
10.2337/diabetes.55.02.06.db05-0680
[29]
Ding J, Strachan MW, Reynolds RM, et al. Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes. 2010; 59: 2883–2889.
10.2337/db10-0752
[30]
Ostenson CG. The Goto-Kakizaki rat. In: Shafrir E, ed. Animal Models of Diabetes: Frontiers in Research. Boca Raton, FL: Taylor & Francis Group; 2007: 119–137.
10.1201/9781420009453.ch5
[31]
Portha B, Serradas P, Bailbe D, Suzuki K, Goto Y, Giroix MH. Beta-cell insensitivity to glucose in the GK rat, a spontaneous nonobese model for type II diabetes. Diabetes. 1991; 40: 486–491.
10.2337/diab.40.4.486
[32]
Matsubara H, Kuze M, Sasoh M, Ma N, Furuta M, Uji Y. Time-dependent course of electroretinograms in the spontaneous diabetic Goto-Kakizaki rat. Jpn J Ophthalmol. 2006; 50: 211–216.
10.1007/s10384-005-0315-8
[33]
Fan Y, Liu K, Wang Q, Ruan Y, Zhang Y, Ye W. Exendin-4 protects retinal cells from early diabetes in Goto-Kakizaki rats by increasing the Bcl-2/Bax and Bcl-xL/Bax ratios and reducing reactive gliosis. Mol Vis. 2014; 20: 1557–1568.
[34]
Li XH, Xin X, Wang Y, et al. Pentamethylquercetin protects against diabetes-related cognitive deficits in diabetic Goto-Kakizaki rats. J Alzheimers Dis. 2013; 34: 755–767.
10.3233/jad-122017
[35]
Lietzau G, Davidsson W, Ostenson CG, et al. Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin. Acta Neuropathol Commun. 2018; 6: 14.
10.1186/s40478-018-0517-1
[36]
Moreira T, Malec E, Ostenson CG, Efendic S, Liljequist S. Diabetic type II Goto-Kakizaki rats show progressively decreasing exploratory activity and learning impairments in fixed and progressive ratios of a lever-press task. Behav Brain Res. 2007; 180: 28–41.
10.1016/j.bbr.2007.02.034
[37]
Suzuki K, Saito N, Sakata Y, Toyota T, Goto Y. A new prostaglandin E1 analogue (TFC-612) improves the reduction in motor nerve conduction velocity in spontaneously diabetic GK (Goto-Kakizaki) rats. Prostaglandins. 1990; 40: 463–471.
10.1016/0090-6980(90)90109-9
[38]
National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals. 8th ed. Washington DC: National Academies Press (US); 2011.
[39]
Goto Y, Kakizaki M, Masaki N. Production of spontaneous diabetic rats by repetition of selective breeding. Tohoku J Exp Med. 1976; 119: 85–90.
10.1620/tjem.119.85
[40]
Allen RS, Hanif AM, Gogniat MA, et al. TrkB signalling pathway mediates the protective effects of exercise in the diabetic rat retina. Eur J Neurosci. 2018; 47: 1254–1265.
10.1111/ejn.13909
[41]
Precht W, Cazin L. Functional deficits in the optokinetic system of albino rats. Exp Brain Res. 1979; 37: 183–186.
10.1007/bf01474264
[42]
Allen RS, Olsen TW, Sayeed I, et al. Progesterone treatment in two rat models of ocular ischemia. Invest Ophthalmol Vis Sci. 2015; 56: 2880–2891.
10.1167/iovs.14-16070
[43]
Aung MH, Park HN, Han MK, et al. Dopamine deficiency contributes to early visual dysfunction in a rodent model of type 1 diabetes. J Neurosci. 2014; 34: 726–736.
10.1523/jneurosci.3483-13.2014
[44]
Turner PV, Albassam MA. Susceptibility of rats to corneal lesions after injectable anesthesia. Comp Med. 2005; 55: 175–182.
[45]
Allen R, Motz CT, Feola A, et al. Long-term functional and structural consequences of primary blast overpressure to the eye. J Neurotrauma. 2018 35: 2104–2116.
10.1089/neu.2017.5394
[46]
Maurice T, Bayle J, Privat A. Learning impairment following acute administration of the calcium channel antagonist nimodipine in mice. Behav Pharmacol. 1995; 6: 167–175.
10.1097/00008877-199503000-00009
[47]
Nascimento PS, Lovatel GA, Barbosa S, et al. Treadmill training improves motor skills and increases tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta in diabetic rats. Brain Res. 2011; 1382: 173–180.
10.1016/j.brainres.2011.01.063
[48]
Hardigan T, Yasir A, Abdelsaid M, et al. Linagliptin treatment improves cerebrovascular function and remodeling and restores reduced cerebral perfusion in Type 2 diabetes. Am J Physiol Regul Integr Comp Physiol. 2016; 311: R466–R477.
10.1152/ajpregu.00057.2016
[49]
Matsunaga Y, Negishi T, Hatakeyama A, Kawagoe Y, Sawano E, Tashiro T. Impairment of synaptic development in the hippocampus of diabetic Goto-Kakizaki rats. Int J Dev Neurosci. 2016; 53: 58–67.
10.1016/j.ijdevneu.2016.07.004
[50]
Jenkins TC, Cartwright JP. The electroretinogram in minimal diabetic retinopathy. The Br J Ophthalmol. 1990; 74: 681–684.
10.1136/bjo.74.11.681
Showing 50 of 59 references
Cited By
27
Abnormal changes of brain function and structure in patients with T2DM-related cognitive impairment: a neuroimaging meta-analysis and an independent validation
Nutrition & Diabetes
Pan Dai, Ying Yu · 2024
Altered pattern separation in Goto-Kakizaki rats
Current Research in Neurobiology
Chelsey C. Damphousse, Jaclyn K. Medeiros · 2023
Metrics
27
Citations
59
References
Details
- Published
- Jan 14, 2019
- Vol/Issue
- 60(1)
- Pages
- 123
- License
- View
Authors
Cite This Article
Rachael S. Allen, Andrew Feola, Cara T. Motz, et al. (2019). Retinal Deficits Precede Cognitive and Motor Deficits in a Rat Model of Type II Diabetes. Investigative Opthalmology & Visual Science, 60(1), 123. https://doi.org/10.1167/iovs.18-25110
Related
You May Also Like
Improved Automated Detection of Diabetic Retinopathy on a Publicly Available Dataset Through Integration of Deep Learning
Michael David Abràmoff, Yiyue Lou · 2016
941 citations
IMI – Defining and Classifying Myopia: A Proposed Set of Standards for Clinical and Epidemiologic Studies
Daniel Ian Flitcroft, Jost B. Jonas · 2019
901 citations
The Complications of Myopia: A Review and Meta-Analysis
Annechien E. G. Haarman, Clair A. Enthoven · 2020
714 citations
Retardation of Myopia in Orthokeratology (ROMIO) Study: A 2-Year Randomized Clinical Trial
Pauline Cho, Sin-Wan Cheung · 2012
656 citations
Diurnal Variation of Choroidal Thickness in Normal, Healthy Subjects Measured by Spectral Domain Optical Coherence Tomography
Colin S. Tan, Yanling Ouyang · 2012
623 citations